Suppr超能文献

泌乳素分泌型垂体瘤患者中多巴胺能对泌乳素分泌的抑制作用的中枢神经系统成分缺失。

Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.

作者信息

Fine S A, Frohman L A

出版信息

J Clin Invest. 1978 Apr;61(4):973-80. doi: 10.1172/JCI109022.

Abstract

The administration of l-dopa suppresses prolactin (PRL) secretion in normal subjects and in patients with hyperprolactinemia, although it is not known whether this effect, which requires the conversion of dopa to dopamine, is mediated peripherally or through the central nervous system. To distinguish between these effects, 10 normal subjects (6 male, 4 female) and 8 patients with hyperprolactinemia associated with pituitary tumors were given l-dopa, 0.5 g alone, or 0.1 g after a 24-h pretreatment with carbidopa, 50 mg every 6 h, which produces peripheral dopa decarboxylase inhibition. Similar degrees of PRL suppression were observed in normal subjects (basal plasma PRL 13+/-2 ng/ml) after l-dopa alone (48+/-4%) and after l-dopa plus carbidopa (58+/-6%). In patients with pituitary tumors and elevated plasma PRL (73+/-14 ng/ml), l-dopa alone led to PRL suppression comparable with that in normal subjects (47+/-6%). However, l-dopa plus carbidopa resulted in only minimal suppression of plasma PRL (19+/-4%) which was significantly less than after l-dopa alone (P < 0.001). Urinary homovanillic acid excretion, which reflected peripheral dopa decarboxylation was similar in controls and tumor patients after l-dopa both alone and after carbidopa pretreatment. Comparable suppression of PRL levels in response to a dopamine infusion (4 mug/kg per min for 3 h) was observed in controls and tumor patients. The results indicate that although peripheral conversion of exogenous dopa to dopamine can suppress PRL secretion, in normals, the central nervous system conversion of dopa to dopamine in the presence of peripheral dopa decarboxylase inhibition is sufficient to account for its PRL-suppressive effects. In contrast, patients with tumors, while retaining peripheral dopaminergic inhibitory effects on PRL secretion, exhibit a marked reduction of central dopaminergic inhibition of PRL secretion.

摘要

左旋多巴的给药可抑制正常受试者及高泌乳素血症患者的泌乳素(PRL)分泌,不过尚不清楚这种需将多巴转化为多巴胺的效应是通过外周介导还是通过中枢神经系统介导。为区分这些效应,对10名正常受试者(6名男性,4名女性)和8名患有与垂体肿瘤相关的高泌乳素血症患者给予左旋多巴,单独给予0.5 g,或在每6小时给予50 mg卡比多巴进行24小时预处理后给予0.1 g,卡比多巴可抑制外周多巴脱羧酶。在正常受试者(基础血浆PRL为13±2 ng/ml)中,单独给予左旋多巴后(48±4%)和给予左旋多巴加卡比多巴后(58±6%)观察到相似程度的PRL抑制。在垂体肿瘤患者且血浆PRL升高(73±14 ng/ml)时,单独给予左旋多巴导致的PRL抑制与正常受试者相当(47±6%)。然而,左旋多巴加卡比多巴仅导致血浆PRL的最小抑制(19±4%),这明显低于单独给予左旋多巴后的抑制(P<0.001)。反映外周多巴脱羧作用的尿高香草酸排泄在单独给予左旋多巴以及卡比多巴预处理后的对照组和肿瘤患者中相似。在对照组和肿瘤患者中观察到对多巴胺输注(每分钟4 μg/kg,持续3小时)的PRL水平有类似抑制。结果表明,尽管外源性多巴在外周转化为多巴胺可抑制PRL分泌,但在正常情况下,在外周多巴脱羧酶抑制存在时,多巴在中枢神经系统转化为多巴胺足以解释其对PRL的抑制作用。相比之下,肿瘤患者虽然保留了外周多巴胺能对PRL分泌的抑制作用,但中枢多巴胺能对PRL分泌的抑制作用明显降低。

相似文献

2
Integrity of central dopaminergic system in women with postpartum hyperprolactinemia.
Am J Obstet Gynecol. 1982 Aug 15;143(8):883-7. doi: 10.1016/0002-9378(82)90467-7.
6
Surgical cure of prolactinoma reverses abnormal prolactin repsonse to carbidopa/L-dopa.
J Clin Endocrinol Metab. 1982 Dec;55(6):1118-23. doi: 10.1210/jcem-55-6-1118.
8
Evaluation of hypothalamic dopaminergic function in patients with pituitary prolactinoma.
Proc Chin Acad Med Sci Peking Union Med Coll. 1989;4(3):121-5.
10
Effects of CNS dopamine augmentation on stimulated prolactin secretion.
J Clin Endocrinol Metab. 1977 Oct;45(4):857-60. doi: 10.1210/jcem-45-4-857.

引用本文的文献

1
Trends in the management of prolactinomas.催乳素瘤的管理趋势。
Br Med J. 1980 Aug 2;281(6236):338-9. doi: 10.1136/bmj.281.6236.338.
5
Nomifensine-induced pregnancy in a hyperprolactinemic woman.
J Endocrinol Invest. 1982 Mar-Apr;5(2):129-30. doi: 10.1007/BF03350505.
6
Effects of increased central dopaminergic tonus on gonadotropin secretion.
J Endocrinol Invest. 1981 Apr-Jun;4(2):237-40. doi: 10.1007/BF03350460.
10
Long term bromocriptine therapy in Cushing's disease.库欣病的长期溴隐亭治疗
J Endocrinol Invest. 1982 Mar-Apr;5(2):117-20. doi: 10.1007/BF03350502.

本文引用的文献

7
Growth hormone dynamics in acromegaly.
J Clin Endocrinol Metab. 1970 Sep;31(3):239-47. doi: 10.1210/jcem-31-3-239.
10
Purification of prolactin-releasing and inhibiting factors from beef.
Endocrinology. 1974 Feb;94(2):563-7. doi: 10.1210/endo-94-2-563.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验